Advertisement

Index by author

April 01, 2023; Volume 103,Issue 4

A

  1. Ahmadinejad, Fereshteh

    1. Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice
      Chaoling Chen, Weili Wang, Marissa Raymond, Fereshteh Ahmadinejad, Justin L. Poklis, Brandon Em, David A. Gewirtz, Aron H. Lichtman and Ningjun Li
      Molecular Pharmacology April 2023, 103 (4) 230-240; DOI: https://doi.org/10.1124/molpharm.122.000618

  2. Akahane, Koushi

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

  3. Auner, Gregory

    1. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain
      Claire Soave, Charles Ducker, Naeyma Islam, Seongho Kim, Sally Yurgelevic, Nathan I. Nicely, Luke Pardy, Yanfang Huang, Peter E. Shaw, Gregory Auner, Alex Dickson and Manohar Ratnam
      Molecular Pharmacology April 2023, 103 (4) 211-220; DOI: https://doi.org/10.1124/molpharm.122.000589

B

  1. Bean, Bruce P.

    1. Use-Dependent Relief of Inhibition of Nav1.8 Channels by A-887826
      Sooyeon Jo, Han-Xiong Bear Zhang and Bruce P. Bean
      Molecular Pharmacology April 2023, 103 (4) 221-229; DOI: https://doi.org/10.1124/molpharm.122.000593

C

  1. Chen, Chaoling

    1. Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice
      Chaoling Chen, Weili Wang, Marissa Raymond, Fereshteh Ahmadinejad, Justin L. Poklis, Brandon Em, David A. Gewirtz, Aron H. Lichtman and Ningjun Li
      Molecular Pharmacology April 2023, 103 (4) 230-240; DOI: https://doi.org/10.1124/molpharm.122.000618

D

  1. Dickson, Alex

    1. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain
      Claire Soave, Charles Ducker, Naeyma Islam, Seongho Kim, Sally Yurgelevic, Nathan I. Nicely, Luke Pardy, Yanfang Huang, Peter E. Shaw, Gregory Auner, Alex Dickson and Manohar Ratnam
      Molecular Pharmacology April 2023, 103 (4) 211-220; DOI: https://doi.org/10.1124/molpharm.122.000589

  2. Dong, Yanqun

    1. A Novel Role of Uricosuric Agent Benzbromarone in BK Channel Activation and Reduction of Airway Smooth Muscle Contraction
      Jian Gao, Hao Yin, Yanqun Dong, Xintong Wang, Yani Liu and KeWei Wang
      Molecular Pharmacology April 2023, 103 (4) 241-254; DOI: https://doi.org/10.1124/molpharm.122.000638

  3. Ducker, Charles

    1. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain
      Claire Soave, Charles Ducker, Naeyma Islam, Seongho Kim, Sally Yurgelevic, Nathan I. Nicely, Luke Pardy, Yanfang Huang, Peter E. Shaw, Gregory Auner, Alex Dickson and Manohar Ratnam
      Molecular Pharmacology April 2023, 103 (4) 211-220; DOI: https://doi.org/10.1124/molpharm.122.000589

E

  1. Em, Brandon

    1. Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice
      Chaoling Chen, Weili Wang, Marissa Raymond, Fereshteh Ahmadinejad, Justin L. Poklis, Brandon Em, David A. Gewirtz, Aron H. Lichtman and Ningjun Li
      Molecular Pharmacology April 2023, 103 (4) 230-240; DOI: https://doi.org/10.1124/molpharm.122.000618

G

  1. Gao, Jian

    1. A Novel Role of Uricosuric Agent Benzbromarone in BK Channel Activation and Reduction of Airway Smooth Muscle Contraction
      Jian Gao, Hao Yin, Yanqun Dong, Xintong Wang, Yani Liu and KeWei Wang
      Molecular Pharmacology April 2023, 103 (4) 241-254; DOI: https://doi.org/10.1124/molpharm.122.000638

  2. Gewirtz, David A.

    1. Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice
      Chaoling Chen, Weili Wang, Marissa Raymond, Fereshteh Ahmadinejad, Justin L. Poklis, Brandon Em, David A. Gewirtz, Aron H. Lichtman and Ningjun Li
      Molecular Pharmacology April 2023, 103 (4) 230-240; DOI: https://doi.org/10.1124/molpharm.122.000618

  3. Goi, Kumiko

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

H

  1. Harama, Daisuke

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

  2. Hosaka, Masumi

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

  3. Huang, Yanfang

    1. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain
      Claire Soave, Charles Ducker, Naeyma Islam, Seongho Kim, Sally Yurgelevic, Nathan I. Nicely, Luke Pardy, Yanfang Huang, Peter E. Shaw, Gregory Auner, Alex Dickson and Manohar Ratnam
      Molecular Pharmacology April 2023, 103 (4) 211-220; DOI: https://doi.org/10.1124/molpharm.122.000589

I

  1. Inukai, Takeshi

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

  2. Islam, Naeyma

    1. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain
      Claire Soave, Charles Ducker, Naeyma Islam, Seongho Kim, Sally Yurgelevic, Nathan I. Nicely, Luke Pardy, Yanfang Huang, Peter E. Shaw, Gregory Auner, Alex Dickson and Manohar Ratnam
      Molecular Pharmacology April 2023, 103 (4) 211-220; DOI: https://doi.org/10.1124/molpharm.122.000589

J

  1. Jo, Sooyeon

    1. Use-Dependent Relief of Inhibition of Nav1.8 Channels by A-887826
      Sooyeon Jo, Han-Xiong Bear Zhang and Bruce P. Bean
      Molecular Pharmacology April 2023, 103 (4) 221-229; DOI: https://doi.org/10.1124/molpharm.122.000593

K

  1. Kagami, Keiko

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

  2. Kasai, Shin

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

  3. Kim, Seongho

    1. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain
      Claire Soave, Charles Ducker, Naeyma Islam, Seongho Kim, Sally Yurgelevic, Nathan I. Nicely, Luke Pardy, Yanfang Huang, Peter E. Shaw, Gregory Auner, Alex Dickson and Manohar Ratnam
      Molecular Pharmacology April 2023, 103 (4) 211-220; DOI: https://doi.org/10.1124/molpharm.122.000589

  4. Komatsu, Chiaki

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

L

  1. Li, Ningjun

    1. Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice
      Chaoling Chen, Weili Wang, Marissa Raymond, Fereshteh Ahmadinejad, Justin L. Poklis, Brandon Em, David A. Gewirtz, Aron H. Lichtman and Ningjun Li
      Molecular Pharmacology April 2023, 103 (4) 230-240; DOI: https://doi.org/10.1124/molpharm.122.000618

  2. Lichtman, Aron H.

    1. Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice
      Chaoling Chen, Weili Wang, Marissa Raymond, Fereshteh Ahmadinejad, Justin L. Poklis, Brandon Em, David A. Gewirtz, Aron H. Lichtman and Ningjun Li
      Molecular Pharmacology April 2023, 103 (4) 230-240; DOI: https://doi.org/10.1124/molpharm.122.000618

  3. Liu, Yani

    1. A Novel Role of Uricosuric Agent Benzbromarone in BK Channel Activation and Reduction of Airway Smooth Muscle Contraction
      Jian Gao, Hao Yin, Yanqun Dong, Xintong Wang, Yani Liu and KeWei Wang
      Molecular Pharmacology April 2023, 103 (4) 241-254; DOI: https://doi.org/10.1124/molpharm.122.000638

N

  1. Nguyen, Thao Thu Thi

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

  2. Nicely, Nathan I.

    1. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain
      Claire Soave, Charles Ducker, Naeyma Islam, Seongho Kim, Sally Yurgelevic, Nathan I. Nicely, Luke Pardy, Yanfang Huang, Peter E. Shaw, Gregory Auner, Alex Dickson and Manohar Ratnam
      Molecular Pharmacology April 2023, 103 (4) 211-220; DOI: https://doi.org/10.1124/molpharm.122.000589

P

  1. Pardy, Luke

    1. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain
      Claire Soave, Charles Ducker, Naeyma Islam, Seongho Kim, Sally Yurgelevic, Nathan I. Nicely, Luke Pardy, Yanfang Huang, Peter E. Shaw, Gregory Auner, Alex Dickson and Manohar Ratnam
      Molecular Pharmacology April 2023, 103 (4) 211-220; DOI: https://doi.org/10.1124/molpharm.122.000589

  2. Poklis, Justin L.

    1. Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice
      Chaoling Chen, Weili Wang, Marissa Raymond, Fereshteh Ahmadinejad, Justin L. Poklis, Brandon Em, David A. Gewirtz, Aron H. Lichtman and Ningjun Li
      Molecular Pharmacology April 2023, 103 (4) 230-240; DOI: https://doi.org/10.1124/molpharm.122.000618

R

  1. Ratnam, Manohar

    1. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain
      Claire Soave, Charles Ducker, Naeyma Islam, Seongho Kim, Sally Yurgelevic, Nathan I. Nicely, Luke Pardy, Yanfang Huang, Peter E. Shaw, Gregory Auner, Alex Dickson and Manohar Ratnam
      Molecular Pharmacology April 2023, 103 (4) 211-220; DOI: https://doi.org/10.1124/molpharm.122.000589

  2. Raymond, Marissa

    1. Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice
      Chaoling Chen, Weili Wang, Marissa Raymond, Fereshteh Ahmadinejad, Justin L. Poklis, Brandon Em, David A. Gewirtz, Aron H. Lichtman and Ningjun Li
      Molecular Pharmacology April 2023, 103 (4) 230-240; DOI: https://doi.org/10.1124/molpharm.122.000618

S

  1. Sanada, Masashi

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

  2. Shaw, Peter E.

    1. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain
      Claire Soave, Charles Ducker, Naeyma Islam, Seongho Kim, Sally Yurgelevic, Nathan I. Nicely, Luke Pardy, Yanfang Huang, Peter E. Shaw, Gregory Auner, Alex Dickson and Manohar Ratnam
      Molecular Pharmacology April 2023, 103 (4) 211-220; DOI: https://doi.org/10.1124/molpharm.122.000589

  3. Soave, Claire

    1. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain
      Claire Soave, Charles Ducker, Naeyma Islam, Seongho Kim, Sally Yurgelevic, Nathan I. Nicely, Luke Pardy, Yanfang Huang, Peter E. Shaw, Gregory Auner, Alex Dickson and Manohar Ratnam
      Molecular Pharmacology April 2023, 103 (4) 211-220; DOI: https://doi.org/10.1124/molpharm.122.000589

  4. Somazu, Shinpei

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

T

  1. Tamai, Minori

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

  2. Tanaka, Yoichi

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

W

  1. Wang, KeWei

    1. A Novel Role of Uricosuric Agent Benzbromarone in BK Channel Activation and Reduction of Airway Smooth Muscle Contraction
      Jian Gao, Hao Yin, Yanqun Dong, Xintong Wang, Yani Liu and KeWei Wang
      Molecular Pharmacology April 2023, 103 (4) 241-254; DOI: https://doi.org/10.1124/molpharm.122.000638

  2. Wang, Weili

    1. Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice
      Chaoling Chen, Weili Wang, Marissa Raymond, Fereshteh Ahmadinejad, Justin L. Poklis, Brandon Em, David A. Gewirtz, Aron H. Lichtman and Ningjun Li
      Molecular Pharmacology April 2023, 103 (4) 230-240; DOI: https://doi.org/10.1124/molpharm.122.000618

  3. Wang, Xintong

    1. A Novel Role of Uricosuric Agent Benzbromarone in BK Channel Activation and Reduction of Airway Smooth Muscle Contraction
      Jian Gao, Hao Yin, Yanqun Dong, Xintong Wang, Yani Liu and KeWei Wang
      Molecular Pharmacology April 2023, 103 (4) 241-254; DOI: https://doi.org/10.1124/molpharm.122.000638

  4. Watanabe, Atsushi

    1. CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model
      Thao Thu Thi Nguyen, Yoichi Tanaka, Masashi Sanada, Masumi Hosaka, Minori Tamai, Keiko Kagami, Chiaki Komatsu, Shinpei Somazu, Daisuke Harama, Shin Kasai, Atsushi Watanabe, Koushi Akahane, Kumiko Goi and Takeshi Inukai
      Molecular Pharmacology April 2023, 103 (4) 199-210; DOI: https://doi.org/10.1124/molpharm.122.000546

Y

  1. Yin, Hao

    1. A Novel Role of Uricosuric Agent Benzbromarone in BK Channel Activation and Reduction of Airway Smooth Muscle Contraction
      Jian Gao, Hao Yin, Yanqun Dong, Xintong Wang, Yani Liu and KeWei Wang
      Molecular Pharmacology April 2023, 103 (4) 241-254; DOI: https://doi.org/10.1124/molpharm.122.000638

  2. Yurgelevic, Sally

    1. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain
      Claire Soave, Charles Ducker, Naeyma Islam, Seongho Kim, Sally Yurgelevic, Nathan I. Nicely, Luke Pardy, Yanfang Huang, Peter E. Shaw, Gregory Auner, Alex Dickson and Manohar Ratnam
      Molecular Pharmacology April 2023, 103 (4) 211-220; DOI: https://doi.org/10.1124/molpharm.122.000589

Z

  1. Zhang, Han-Xiong Bear

    1. Use-Dependent Relief of Inhibition of Nav1.8 Channels by A-887826
      Sooyeon Jo, Han-Xiong Bear Zhang and Bruce P. Bean
      Molecular Pharmacology April 2023, 103 (4) 221-229; DOI: https://doi.org/10.1124/molpharm.122.000593
Back to top

In this issue

Advertisement